Mark Leahey is the President & CEO for the Medical Device Manufacturers Association (MDMA), the leading national trade association representing hundreds of innovative and entrepreneurial medical technology companies in Washington, DC. His responsibilities include advocating on behalf of the medical device industry to Congress, the Food and Drug Administration (FDA), the Centers for Medicare and Medicaid Services (CMS), and other federal and state agencies. He has led efforts for more reasonable and predictable regulatory pathways for innovators, a more timely and fair reimbursement process, and worked to open access in the hospital marketplace for all medical devices. Mr. Leahey led efforts against the medical device tax when it was first proposed in 2009, and successfully advocated for multiple suspensions of the tax before securing a full repeal in 2019. He has been named one of the medical device industry’s top lobbyists and has served as one of the lead negotiators for the medical technology industry during every user fee agreement. Leahey currently serves on the Board of Directors for the Fogarty Institute, a leading medical technology incubator, and the Executive Board of EXCITE International, a global collaborative seeking to accelerate access to health technologies and the Editorial Advisory Board of Medical Product Outsourcing. He is a member of the Massachusetts Bar and a graduate of Georgetown University, the Georgetown Law Center and Georgetown’s McDonough School of Business.